MarketFriction

Metropolis Healthcare Ltd

NSE METROPOLIS · BSE 542650 · Healthcare Service Provider
₹537.90 -0.70%
NSE close2026-10-01
52 week range412.25 - 609.05
Market cap₹11,665 Cr.
P/E56.0
IPO 2019 · +144% since Microcap 250 Price band 20% Delivery 65.5%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales308291331313350323345386429406425450
Expenses234226251235260251283296321311317339
Operating Profit756580799072629010895108111
OPM %24%22%24%25%26%22%18%23%25%23%25%25%
Other Income123233781-085
Interest656555556686
Depreciation222526262728293132323932
Profit before tax483751516142366171577078
Tax %26%26%28%25%24%26%19%26%26%26%27%27%
Net Profit362737384731294553425157
EPS in Rs1.731.331.781.852.271.531.412.172.542.002.462.73
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales4755456477618569981,2281,1481,2081,3311,6461,710
Expenses3594054675596197088808559201,0231,2401,288
Operating Profit116140181203237290348293288308406422
OPM %24%26%28%27%28%29%28%26%24%23%25%25%
Other Income293968-171234159151614
Interest22441312253228242926
Depreciation171719203946638994109134135
Profit before tax128160164187169244293188175191259276
Tax %36%33%32%34%24%25%27%24%26%24%26%
Net Profit82107112124128183215143128146191203
EPS in Rs20.1026.6127.295.996.298.9510.466.986.247.009.179.73
Dividend Payout %100%49%0%55%32%22%19%29%16%0%55%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth13%11%13%22%
Compounded Profit Growth11%1%11%37%
Stock Price CAGR%-4%16%10%
Return on Equity19%15%12%14%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital101010101010101010101041
Reserves3522693144054085136968769781,0861,3211,472
Borrowings145111867112379266197204232
Other Liabilities87107188110113160181256240254324386
Total Liabilities4623915125265507501,0001,5211,4951,5471,8592,131
Fixed Assets1531422022072132963431,0591,1211,1771,4471,601
CWIP0110630620000
Investments16810114210233141016155571142
Other Assets141147167216298437647440340316341387
Total Assets4623915125265507501,0001,5211,4951,5471,8592,131
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity699110210490215249253247264263351
Cash from Investing Activity-5696-86136-10463-73648-89-199-220
Cash from Financing Activity-9-174-17-87-118-55-33163-292-181-87-115
Net Cash Flow414-118856279-3213-6-2315
Free Cash Flow4679459067179221223195200196300
CFO/OP87%113%109%89%78%118%106%96%102%105%99%98%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days575454576655454039384138
Inventory Days524638535544596864586551
Days Payable9296978890152160136136150171146
Cash Conversion Cycle173-52130-54-56-29-33-53-65-57
Working Capital Days328-2728332-9-26-22-16-18-15
ROCE %28%34%46%43%43%40%36%29%17%16%15%18%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters49.75%49.74%49.67%49.62%49.43%49.40%48.89%48.89%48.89%48.87%48.86%48.86%
FIIs24.29%21.66%18.90%18.25%18.56%16.73%15.29%12.83%12.52%11.68%10.43%11.03%
DIIs16.86%20.73%24.86%27.42%28.02%30.00%30.30%32.40%33.10%34.73%35.80%35.12%
Public9.10%7.87%6.57%4.69%3.98%3.86%5.51%5.87%5.48%4.69%4.92%5.00%
No. of Shareholders86,24979,87868,28358,10851,85248,57249,29350,01547,84646,67049,17550,636

Fundamentals

Market Cap₹ 11,665 Cr.
Current Price₹ 562
Stock P/E56.0
Book Value₹ 73.0
ROCE17.8 %
ROE13.6 %
Dividend Yield0.36 %
Face Value₹ 2.00
Compounded Sales Growth (TTM)22%
Compounded Profit Growth (TTM)37%
Consolidated figures.
Valuation
Market capRs 11,152 Cr
Enterprise valueRs 11,322 Cr
P/E (TTM)55.31x
Price to book7.37x
Price to sales6.52x
EV / EBITDA25.94x
EV / EBIT37.59x
EV / sales6.62x
Price to cash flow31.80x
Earnings yield1.81%
Dividend yield0.93%
P/E, 3-year average26.20x
P/B, 3-year average3.16x
P/E, 5-year average20.39x
P/B, 5-year average2.81x
Profitability
Operating margin (excl. other income)24.66%
Operating margin (incl. other income)25.63%
EBITDA margin25.52%
Pre-tax margin16.12%
Net profit margin11.79%
Net margin, latest quarter12.59%
ROE13.36%
ROCE17.57%
ROA9.52%
ROE, 3-year average12.52%
ROCE, 3-year average16.22%
ROA, 3-year average8.81%
ROE, 5-year average15.94%
ROCE, 5-year average19.32%
ROA, 5-year average10.58%
ROIC (approx.)13.20%
Tax rate26.23%
Other income / net worth1.05%
Growth
Sales growth (latest year)23.64%
Profit growth (latest year)31.08%
Sales CAGR, 3 years12.75%
Sales CAGR, 5 years10.52%
Profit CAGR, 3 years9.97%
Profit CAGR, 5 years0.74%
Sales growth QoQ6.01%
Profit growth QoQ11.34%
Sales growth YoY (latest quarter)16.62%
Profit growth YoY (latest quarter)25.77%
Per share
EPS (TTM)Rs 9.73
EPS (latest year)Rs 9.17
EPS (latest quarter)Rs 2.73
EPS, 3-year averageRs 20.70
EPS, 5-year averageRs 26.37
Book value per shareRs 72.98
Sales per shareRs 82.48
Cash flow per shareRs 16.92
Free cash flow per shareRs 14.47
Dividend per share (latest year)Rs 5.00
Dividend per share, 3-year averageRs 4.50
Dividend per share, 5-year averageRs 6.25
Dividends
Dividend payout54.56%
Dividend payout, 3-year average35.30%
Dividend payout, 5-year average29.59%
Efficiency
Asset turnover0.77x
Fixed asset turnover1.03x
Inventory turnover9.09x
Inventory days40 days
Debtor days38 days
Debtors turnover9.66x
Creditor days146 days
Cash conversion cycle-57 days
Working capital days-15 days
Leverage
Total debtRs 232 Cr
Cash and bankRs 62 Cr
Net debtRs 170 Cr
Debt to equity0.15x
Net debt / EBITDA0.39x
Interest coverage11.80x
Current ratio (filing 2026-03-31)1.40x
Quick ratio (filing 2026-03-31)1.27x
Trade payables (filing 2026-03-31)Rs 129 Cr
Owners' fund to total sources71.01%
Debt to assets10.88%
Cash flow
Cash from Operating Activity (latest year)Rs 351 Cr
Cash from Investing Activity (latest year)Rs -220 Cr
Cash from Financing Activity (latest year)Rs -115 Cr
Net Cash Flow (latest year)Rs 15 Cr
Free cash flow (latest year)Rs 300 Cr
FCFE (approx.: FCF + change in debt)Rs 328 Cr
Cash from ops / profit, 5 years1.67x
Sales to cash flow4.69x
Statement figures
Net sales (TTM)Rs 1,710 Cr
Net sales (latest year)Rs 1,646 Cr
Sales (latest quarter)Rs 450 Cr
Operating profit excl. other income (latest year)Rs 406 Cr
Operating profit (latest quarter)Rs 111 Cr
Other income (TTM)Rs 14 Cr
EBITDA (TTM)Rs 436 Cr
PBDT (TTM)Rs 411 Cr
Profit before tax (TTM)Rs 276 Cr
Tax (latest year)Rs 68 Cr
Net profit (TTM)Rs 202 Cr
Net profit (latest year)Rs 190 Cr
Net profit (latest quarter)Rs 57 Cr
Depreciation (TTM)Rs 135 Cr
Depreciation (latest quarter)Rs 32 Cr
Interest (TTM)Rs 26 Cr
Cost of goods sold (latest year)Rs 413 Cr
Total expenditure (latest year)Rs 1,240 Cr
Total income (latest year)Rs 1,662 Cr
Share capitalRs 41 Cr
ReservesRs 1,472 Cr
Shareholders' fundsRs 1,513 Cr
Total assetsRs 2,131 Cr
Net blockRs 1,601 Cr
InvestmentsRs 142 Cr
ReceivablesRs 170 Cr
InventoryRs 45 Cr
Other liabilitiesRs 386 Cr
Shares outstanding (crore)20.73
Ownership
Promoter holding48.86% (-0.03 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 55.3 is at the 31th percentile of its own 7.6-year range (median 60.9, low 30.2, high 105.2).
P/B 7.37 is at the 8th percentile (median 9.82).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodMETROPOLISNifty 50Difference
1 week-7.7%-2.8% -4.9 pts
1 month-7.6%-6.8% -0.8 pts
3 months-3.3%-7.6% +4.4 pts
6 months+23.9%+0.4% +23.5 pts
1 year+6.2%-9.9% +16.1 pts
2 years-1.1%-13.6% +12.5 pts
3 years+47.4%+14.2% +33.2 pts
5 years-22.6%+27.9% -50.5 pts
76 mutual fund schemes hold about ₹4,033 Cr. Over three months 54 bought more and 14 sold (share counts, price move removed).
FundWeightEst. Cr3m shares
HDFC Focused Fund1.40%396 +8%
HDFC Flexi Cap Fund0.33%379 +5%
Kotak Small Cap Fund1.89%372 +6%
Franklin India Small Cap Fund1.85%272 +16%
Nippon India Small Cap Fund0.32%267 +6%
HDFC ELSS-Tax Saver Fund1.17%186 +9%
Canara Rob Small Cap Fund1.20%175 +6%
Franklin India Opportunities Fund1.80%175 +26%
Aditya Birla SL Flexi Cap Fund0.56%163 +3%
HDFC Aggressive Hybrid Fund0.64%143 +12%
ICICI Pru Healthcare Fund-1.74%122 +27%
Tata Business Cycle Fund4.57%119 +12%
UTI Value Fund1.16%111 +6%
UTI Large Cap Fund0.76%92 -23%
Tata Multicap Fund1.78%64 +8%
HDFC Pharma and Healthcare Fund1.90%63 -12%
Kotak Contra Fund1.11%61 +8%
Aditya Birla SL Large & Mid Cap Fund1.02%61 +100%
UTI Small Cap Fund1.07%56 +7%
Sundaram Services Fund0.98%52 +12%
UTI Dividend Yield Fund1.36%51 +10%
Sundaram Services Fund0.98%50 +12%
Aditya Birla SL Multi-Cap Fund0.65%49 +4%
Bandhan Small Cap Fund0.12%42 -7%
Tata Balanced Adv Fund0.45%40 +0%

Red flags

F-score 8 of 8
lookAuditor change Auditor change 2026-05-13: Metropolis Healthcare Limited has informed the Exchange regarding Change in Auditors of the company.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹450 Cr +16.6% vs Jun 2025. Net profit ₹57 Cr +26.7%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Dr Lal Pathlabs Ltd32,73758.228.0 %
Vijaya Diagnostic Centre Ltd15,19281.020.5 %
Thyrocare Technologies Ltd8,70848.235.4 %
Nephrocare Health Services Ltd6,67178.415.3 %
Suraksha Diagnostic Ltd1,84751.617.3 %
Krsnaa Diagnostics Ltd1,79118.112.7 %
3B Blackbio DX Ltd1,39625.125.5 %
One Global Service Provider Ltd1,04614.187.0 %
Health X Platform Ltd9230.03 %
Gaudium IVF and Women Health Ltd83035.929.3 %
Chandan Healthcare Ltd58122.123.3 %
Pramodini Medicare Ltd25914.941.8 %
Aspira Pathlab & Diagnostics Ltd1482.84 %
Choksi Laboratories Ltd13269.29.44 %
Star Imaging and Path Lab Ltd1316.8026.1 %
No bulk or block deals on record.
Ex-dateActionFactor
2026-05-19Interim Dividend - Re 1 Per Share
2026-03-20Bonus 3:10.2500
2025-11-11Interim Dividend - Rs 4 Per Share
2023-11-17Interim Dividend - Rs 4 Per Share
2023-08-10Annual General Meeting
2023-02-23Interim Dividend - Rs 8 Per Share
2022-08-08Annual General Meeting
2022-02-21Interim Dividend - Rs. 8 Per Share
2021-02-17 Interim Dividend - Rs 8 Per Share
2020-02-13 Interim Dividend - Rs 8 Per Share
DateTypeWhat it says
2026-09-09General UpdatesAllotment of 66,312 equity shares under the Metropolis-Restrictive Stock Unit Plan, 2020.
2026-09-07Other RestructuringOther Restructuring
2026-09-02Concall / analyst meetTranscript
2026-08-27Concall / analyst meetLink of Recording
2026-08-27General UpdatesDisclosure under Regulation 30 of SEBI Listing Regulations
2026-08-27Investor PresentationInvestor Presentation
2026-08-20Sale or disposalDisclosure under Regulation 30 of SEBI Listing Regulations
2026-08-20Concall / analyst meetMeeting with investors scheduled on August 27, 2026
2026-08-19Shareholder meetingMetropolis Healthcare Limited has submitted the Exchange a copy Scrutinizers Report of Annual General Meeting held on August 18, 2026
2026-08-18Shareholder meetingProceedings of the 26th Annual General Meeting held on August 18, 2026
2026-08-10Concall / analyst meetTranscript
2026-08-05Concall / analyst meetLink of Recording
2026-08-04Press ReleaseA press release dated August 04, 2026, titled "Metropolis Healthcare reports strong Q1FY27 performance, with revenue up 17% to & Rs. 450 crore and EBI...
2026-08-04Investor PresentationInvestor Presentation
2026-08-04Board meeting outcomeMetropolis Healthcare Limited has submitted to the Exchange, the financial results for the period ended June 30, 2026.
2026-08-04ESOP grantGrant of Stock Benefits
2026-08-04AllotmentAllotment of 18,700 Equity Shares under the Metropolis-Restrictive Stock Unit Plan, 2020
2026-07-28Concall / analyst meetSchedule of Q1FY27 earnings conference call (i.e. post earnings/quarterly call), organized by JM Financial Institutional Securities Limited on Wednesd...
2026-07-27General UpdatesThe Letter to Shareholders containing weblink of Annual Report for the financial year 2025-26 and 26th Annual General Meeting
2026-07-27UpdatesBusiness Responsibility and Sustainability Report for the financial year 2025-26.
2026-07-27Shareholder meetingNotice of Annual General Meeting to be held on August 18, 2026
2026-07-09General UpdatesAllotment of 36,900 equity shares under the Metropolis-Restrictive Stock Unit Plan, 2020.
2026-07-05UpdatesBusiness update for Q1FY27.
2026-06-23Disclosure under SEBI TakeovMetropolis Healthcare Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India ...
2026-06-04Concall / analyst meetThe meeting with investors scheduled on June 08, 2026
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Scrip PE is greater than 50 (4 trailing quarters)

Quick answers

What is the market cap of Metropolis Healthcare Ltd?

Metropolis Healthcare Ltd (METROPOLIS) has a market capitalisation of Rs 11,665 Cr. at the 2026-10-01 close.

What is the P/E ratio of Metropolis Healthcare Ltd?

Metropolis Healthcare Ltd trades at a P/E of 56.0 on trailing twelve-month profit, at the 2026-10-01 close.

What were Metropolis Healthcare Ltd's latest quarterly results?

In the Jun 2026 quarter, Metropolis Healthcare Ltd sales was Rs 450 Cr (+16.6% vs Jun 2025) and net profit was Rs 57 Cr.

What is the 52-week high and low of Metropolis Healthcare Ltd?

The 52-week high is Rs 609.05 and the 52-week low is Rs 412.25.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03